APA (7th ed.) Citation

(2023). Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis.

Chicago Style (17th ed.) Citation

Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis. 2023.

MLA (8th ed.) Citation

Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis. 2023.

Warning: These citations may not always be 100% accurate.